SRD5A2 Expression Is a Predictor of Response to Finasteride in the MTOPS Trial

    March 2023 in “ The Journal of Urology
    Ra'ad Al-Faouri, Christina Sharkey, Zongwei Wang, Aria F. Olumi
    New to Finasteride? There is a guide in the encyclopedia. Read the guide →
    Studysummary This study found that higher baseline expression of SRD5A2 in prostate tissue was associated with a better response to finasteride in men with benign prostatic hyperplasia.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →